Gilead Sciences

Executive Director, Clinical Operations – Regional Head - JAPAC

Singapore, Singapore, Singapore

Not SpecifiedCompensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant field, along with a Master’s degree preferred, and have at least 10 years of experience in clinical operations, with a strong preference for experience in the pharmaceutical industry. Demonstrated leadership experience is essential, and a deep understanding of JAPAC regional healthcare systems and regulatory environments is required.

Responsibilities

The Executive Director, Clinical Operations – Regional Head – JAPAC will provide input into regional strategic plans, offer leadership and guidance for clinical trial management, oversee the strategic, operational, and financial aspects of clinical programs, develop and implement clinical trial strategies, manage CROs and vendors, contribute to regional strategic implementation, assess and manage risks, solve complex problems, and ensure timely communication and stakeholder alignment across the JAPAC region.

Skills

Clinical Operations
Leadership
Strategic Planning
Clinical Trial Management
Risk Assessment
Vendor Management
Stakeholder Alignment
Regulatory Environments

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI